Central Retinal Vein Occlusion (CRVO) adalah suatu gangguan kondisi pembuluh darah retina yang dapat menyebabkan morbiditas okular yang signifikan dengan gambaran klinis oklusi atau trombosis dari vena sentralis retina mengakibatkan statis vena, edem papil, perdarahan pre retina dan perdarahan difus di lapisan serat saraf serta cotton wool spots yang menghasilkan gambaran fundus the blood and thunder. Penatalaksanaan CRVO adalah mengatasi underlying disease dan gejala sisa dari CRVO yaitu edem makula dan neovaskularisasi (NV). Penatalaksanaan edem makula pada CRVO dapat berupa observasi, terapi kortikosteroid, dan intravitreal anti VEGF. Untuk mengatasi NV okular seperti laser fotokoagulasi, dan terapi medikamentosa. Selain itu terdapat beberapa terapi alternatif CRVO yaitu chorioretinal venous anastomosis, tissue plasminogen activator, vitrektomi dan radial optic neurotomy. Dilaporkan seorang wanita usia 59 tahun dengan CRVO OS (tipe iskemik), moderat NPDR OD dan katarak imatur ODS direncanakan injeksi intravitreal triamsinolon OS 4 mg / 0,1 cc di kamar operasi dalam keadaan steril. Tajam penglihatan mata kiri meningkat menjadi 1/60 pada minggu ke-4 dan minggu ke-8 kontrol dan perbaikan pada fundoskopi mata kiri. CRVO biasanya terjadi unilateral, disertai dengan penurunan penglihatan tanpa rasa sakit. Terapi injeksi intravitreal triamsinolon (IVTA) diberikan untuk mengobati edema makula pada CRVO.Kata kunci: central retinal vein ocussion, oklusi vena, IVTA, trombogenesis
AbstrakEntropion involusional adalah malposisi kelopak mata pada lansia. Beberapa faktor penyebab seperti kelemahan palpebra horizontal, kelemahan palpebra vertikal dengan pengurangan atau disinsersi retraktor kelopak mata bawah dan overriding otot orbicularist preseptal. Tanpa penatalaksanaan, kondisi ini bisa menyebabkan ketidaknyamanan okular, epifora dan kornea. Prosedur utamanya adalah prosedur wies dan horizontal tightening yang terdiri dari lateral tarsal strip dan horizontal shortening. Tujuan penelitian ini adalah mengevaluasi hasil rekonstruksi entropion involusional di subbagian okuloplastik bagian mata Rumah Sakit M Djamil Padang. Studi retrospektif terhadap 13 kelopak mata dari 13 pasien dengan entropion involusional antara April 2012 sampai Desember 2015. Pasien dievaluasi bulan ke 6 dan bulan 12 setelah operasi. Kami menganalisis persentase keberhasilan teknik rekonstruksi, rekurensi entropion, dan prolonged ectropionsetelah operasi. Dari 13 kelopak mata yang dioperasi, prosedur wies dilakukan pada 9 kelopak mata (69%). Horizontal tightening yang terdiri dari prosedur wies dikombinasikan dengan teknik lateral tarsal stripdan prosedur wies + horizontal shortening dilakukan pada 3 kelopak mata (23%) dan 1 kelopak mata (8%). Tidak ada prosedur yang gagal. Kekambuhan entropion terjadi pada 2 pasien (15%) yang dioperasi dengan prosedur weiss pada follow up 12 bulan. Dari 13 kelopak mata menjalani operasi entropion, tidak ada prolonged ectropion. Operasi rekonstruksi entropion involusional di Rumah Sakit M Djamil Padang memiliki tingkat keberhasilan yang tinggi dan tingkat kekambuhan yang rendah.Kata kunci: Entropion Involusional, operasi rekonstruksi, prosedur wies, prosedur wies yang dikombinasikan dengan lateral tarsal strip, prosedur wies + horizontal shortening AbstractInvolutional entropion is a common eyelid malposition in elderly. It has several causative factors, including horizontal lid laxity, vertical lid laxity with attenuation or disinsertion of the lower lid retractors and over riding of preseptal orbicularis muscle. Without treatment, the condition can cause ocular discomfort, epiphora and corneal ulceration. The primary procedures are wies, and horizontal tightening which consists of lateral tarsal strip and horizontal shortening. The purpose of this study is to evaluated outcome of involutional entropion surgical reconstruction in oculoplastic subdivision department of ophthalmology M Djamil Hospital Padang. A retrospective study of 13 eyelids of 13 patients with involutional entropion between April 2012-December 2015. Patients were evaluated at 6 and 12 months after surgery. We analyzed the percentage of surgical technique success, recurrence of entropion, and prolonged ectropion after surgery. Of 13 eyelids underwent surgery, wies procedure technique was performed in 9 eyelids (69%). Horizontal tightening which consists of wies procedure combined with lateral tarsal strip technique and wies procedure + horizontal shortening were performed in 3 eyelids (23%) and 1 eyelid (8%). There is...
<p><em>Diabetic retinopathy (RD) is a microvascular complication that often occurs in diabetes mellitus (DM). Retinal ganglion cells (RGC) are reduced in the early stages of DM, even before microvascular abnormalities are seen on the retina. <strong>Methods</strong>: Sample of 35 eyes of non RD RD type 2 patients and 35 mild non proliferative diabetic retinopathy (NPDR) eyes After examination of ophthalmological status, perimetry and optical coherence tomography (OCT) were examined. <strong>Results:</strong> The mean MD on non-RD type 2 DM -2.74 ± 3.5 mild NPDR -5.61 ± 4.5 with p value 0.414. The average non-RD type 2 PSD DM was -3.35 ± 3.3, mild NPDR was 4.16 ± 1.4 with a p value of 0.206. The mean RGC thickness of patients with non-RD type 2 DM was 83.8 ± 7.4 µm, mild NPDR 82.7 ± 8.1 μm. There was a decrease in the value of RGC thickness, MD and PSD in patients with type 2 DM, but it was not statistically significant . <strong>Conclusion</strong>: No significant difference was found in RGC thickness in DM patients between non-RD and mild NPDR. No significant difference was found between MD and PSD in DM patients between non-RD and mild NPDR. No significant relationship was found between RGC thickness and perimetry in DM patients between non-RD and mild NPDR. </em></p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.